135 related articles for article (PubMed ID: 12566077)
1. Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent.
Herzig MC; Trevino AV; Liang H; Salinas R; Waters SJ; MacDonald JR; Woynarowska BA; Woynarowski JM
Biochem Pharmacol; 2003 Feb; 65(4):503-13. PubMed ID: 12566077
[TBL] [Abstract][Full Text] [Related]
2. Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells.
Liang H; Salinas RA; Leal BZ; Kosakowska-Cholody T; Michejda CJ; Waters SJ; Herman TS; Woynarowski JM; Woynarowska BA
Mol Cancer Ther; 2004 Nov; 3(11):1385-96. PubMed ID: 15542777
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle effects and induction of premitotic apoptosis by irofulven in synchronized cancer cells.
Woynarowski JM; Woynarowska BA; Trevino AV; Salinas R; Herman TS; Waters SJ; Macdonald JR
Cancer Biol Ther; 2004 Nov; 3(11):1137-42; discussion 1143-4. PubMed ID: 15467441
[TBL] [Abstract][Full Text] [Related]
4. Irofulven induces apoptosis in breast cancer cells regardless of caspase-3 status.
Herzig MC; Liang H; Johnson AE; Woynarowska B; Woynarowski JM
Breast Cancer Res Treat; 2002 Jan; 71(2):133-43. PubMed ID: 11883439
[TBL] [Abstract][Full Text] [Related]
5. Irofulven (6-hydroxymethylacylfulvene, MGI 114) induces caspase 8 and 9-mediated apoptosis in human pancreatic adenocarcinoma cells.
Wang W; Waters SJ; MacDonald JR; Von Hoff DD; Strodel WE; Miller AR
Anticancer Res; 2001; 21(3B):1789-94. PubMed ID: 11497260
[TBL] [Abstract][Full Text] [Related]
6. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
7. Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114).
Woynarowski JM; Napier C; Koester SK; Chen SF; Troyer D; Chapman W; MacDonald JR
Biochem Pharmacol; 1997 Dec; 54(11):1181-93. PubMed ID: 9416969
[TBL] [Abstract][Full Text] [Related]
8. Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin.
Elliott MJ; Stribinskiene L; Lock RB
Cancer Chemother Pharmacol; 1998; 41(6):457-63. PubMed ID: 9554589
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
Wiltshire T; Senft J; Wang Y; Konat GW; Wenger SL; Reed E; Wang W
Mol Pharmacol; 2007 Apr; 71(4):1051-60. PubMed ID: 17229870
[TBL] [Abstract][Full Text] [Related]
10. Effects of a new synthetic zerumbone pendant derivative (ZPD) on apoptosis induction and anti-migratory effects in human cervical cancer cells.
Saranya J; Dhanya BP; Greeshma G; Radhakrishnan KV; Priya S
Chem Biol Interact; 2017 Dec; 278():32-39. PubMed ID: 28987329
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2.
Kim BE; Lee JH; Kim HS; Kwon OJ; Jeong SW; Kim IK
Exp Mol Med; 2004 Oct; 36(5):444-53. PubMed ID: 15557816
[TBL] [Abstract][Full Text] [Related]
12. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
Schmitt E; Steyaert A; Cimoli G; Bertrand R
Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
[TBL] [Abstract][Full Text] [Related]
13. Irofulven (6-hydroxymethylacylfulvene, MGI 114)-induced apoptosis in human pancreatic cancer cells is mediated by ERK and JNK kinases.
Wang W; Waters SJ; MacDonald JR; Roth C; Shentu S; Freeman J; Von Hoff DD; Miller AR
Anticancer Res; 2002; 22(2A):559-64. PubMed ID: 12014623
[TBL] [Abstract][Full Text] [Related]
14. ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells.
Zhang L; Wei LJ
Life Sci; 2007 Mar; 80(13):1189-97. PubMed ID: 17275856
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
16. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation.
Hoffmann R; von Schwarzenberg K; López-Antón N; Rudy A; Wanner G; Dirsch VM; Vollmar AM
Biochem Pharmacol; 2011 Sep; 82(5):453-63. PubMed ID: 21669190
[TBL] [Abstract][Full Text] [Related]
17. Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line.
Kamarajan P; Sun NK; Sun CL; Chao CC
FEBS Lett; 2001 Sep; 505(2):206-12. PubMed ID: 11566177
[TBL] [Abstract][Full Text] [Related]
18. Pomolic acid may overcome multidrug resistance mediated by overexpression of anti-apoptotic Bcl-2 proteins.
Fernandes J; Weinlich R; Castilho RO; Amarante-Mendes GP; Gattass CR
Cancer Lett; 2007 Jan; 245(1-2):315-20. PubMed ID: 16517065
[TBL] [Abstract][Full Text] [Related]
19. Irofulven: resurgence for alkylating therapy in cancer?
Dent P; Grant S
Cancer Biol Ther; 2004 Nov; 3(11):1143-4. PubMed ID: 15640616
[No Abstract] [Full Text] [Related]
20. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]